Naltrexone can be an important part of treatment for opioid use disorder and alcohol use disorder, but using it safely requires understanding something that is often misunderstood: naltrexone does not make opioid overdose impossible.
Naltrexone is an opioid-receptor antagonist. While active, it can block or substantially reduce the effects of opioids.
That blockade can support recovery, but it creates several safety issues that patients, families, emergency clinicians, dentists and surgeons need to understand.
Two periods require particular attention.
First, a person may attempt to take increasingly large amounts of opioids because the expected effect is blocked. Opioid blockade is not an invitation to test how much opioid can overcome it.
Second, opioid tolerance may be lower after a period without opioids. When naltrexone’s blockade decreases or ends, a dose that a person previously tolerated may become substantially more dangerous.
Naltrexone must also be distinguished from naloxone.
Naltrexone is used as part of ongoing treatment. Naloxone is an emergency medication that can reverse an opioid overdose.
This guide explains what to do during a suspected overdose, why naloxone should be readily available, how to plan for surgery or severe pain, why opioid-free preparation matters before naltrexone is started, how alcohol withdrawal differs from naltrexone treatment, and how long-acting naltrexone implants fit into a wider safety plan.
Do Not Wait to Finish Reading This Article
If a person cannot be awakened, has very slow or stopped breathing, has choking or gurgling breathing, or you suspect an opioid overdose:
- Give naloxone or another available opioid-overdose reversal medication.
- Call 911 immediately.
- Try to keep the person breathing and awake if possible.
- Place them on their side to reduce choking risk.
- Stay with them until emergency help arrives.
If you are outside the United States, contact your local emergency medical service instead of 911.
The difference between naltrexone and naloxone, when overdose risk can increase, how to recognize an opioid overdose, what families should have ready at home, how to prepare for surgery and emergency pain, and how to build your own naltrexone safety roadmap.
Prepared for medical review by Dr. Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry
Review status: Pending clinical approval
View Dr Fergus Law’s Clinical & Scientific Profile →What Naltrexone Does — and Does Not Do
Naltrexone is an opioid-receptor antagonist.
It binds to opioid receptors without activating them and can prevent or substantially reduce the expected effects of opioids while adequate antagonist activity is present.
In the United States, extended-release intramuscular naltrexone is FDA-approved for opioid use disorder following opioid detoxification and for alcohol dependence in appropriate patients.
Naltrexone is intended to be part of a comprehensive treatment plan, not a replacement for counseling, behavioral treatment, recovery planning or appropriate medical follow-up.
Blocks Opioid Receptors
Opioids may produce much less of their expected rewarding or sedating effect while adequate blockade is present.
Can Support Recovery
The antagonist effect can provide additional protection against the reinforcing effects of opioid use while behavioral recovery continues.
Is Not Emergency Naloxone
Naltrexone should never be relied on as an emergency treatment for an opioid overdose.
Naltrexone can reduce opioid effects while active, but patients should never interpret that as permission to experiment with opioids or attempt to overcome the blockade.
Naltrexone vs Naloxone
If somebody on naltrexone has an opioid overdose, naloxone is the emergency medication. Do not attempt to give more naltrexone.
Can You Overdose on Opioids While on Naltrexone?
Yes.
Naltrexone can provide strong opioid-receptor blockade, but the FDA specifically warns that this blockade can be overcome.
A person who attempts to take enough opioids to overcome antagonist activity may expose the body to extremely large opioid concentrations.
That can lead to severe opioid intoxication, respiratory depression, coma and death.
Overdose risk can also increase when naltrexone activity declines because opioid tolerance may have fallen during the period of abstinence or blockade.
Trying to Override Naltrexone
Taking increasingly large amounts of an opioid because the expected effect is not felt can become life-threatening.
Blockade Is Decreasing or Has Ended
Reduced tolerance means a previously familiar opioid dose may no longer be safe.
Its role is better described as one component of treatment and relapse prevention. Overdose preparedness remains necessary.
Why Trying to Overcome Naltrexone Can Be Dangerous
Some patients expect that if an opioid does not produce an immediate effect, taking more will eventually “break through.”
This is exactly the situation patients should be warned against.
The safest rule is straightforward:
Why the End of Naltrexone Treatment Can Be a High-Risk Period
Opioid tolerance decreases when somebody stops using opioids.
Naltrexone treatment can create a prolonged period during which a person is not receiving the opioid doses they previously tolerated.
If the antagonist effect later weakens or ends, returning to an old opioid dose can therefore be particularly dangerous.
End of a Dose Interval
With an injectable product, antagonist activity eventually decreases before the next treatment.
Missed Treatment
Missing follow-up can create uncertainty about how much blockade remains.
Treatment Discontinuation
Sensitivity to opioids may be greater than before treatment.
Uncertain Implant Activity
Implant products vary. Patients should not estimate protection from calendar dates alone.
Do not assume an implant is providing the same degree of blockade throughout its entire expected life. Product release profiles vary, and individual patients should follow the instructions of their treating clinician.
Signs of an Opioid Overdose
An opioid overdose primarily becomes lethal because opioids can suppress the brain’s drive to breathe.
If you are unsure whether somebody is simply intoxicated or overdosing, CDC guidance recommends treating the situation as a suspected overdose.
The person is unconscious or does not respond normally.
Breathing may become extremely slow, irregular or stop.
Abnormal snoring or gurgling can indicate a medical emergency.
Lips, fingertips or skin may change color because of oxygen deprivation.
Profound loss of muscle tone may occur.
Very small pupils can occur during opioid overdose, although this sign alone is not enough to diagnose it.
Emergency Protocol for Suspected Opioid Overdose
Give Naloxone
Use an opioid-overdose reversal medication immediately if available.
Call 911
Emergency medical help is needed even when the person appears to respond to naloxone.
Support Breathing
Try to keep the person awake and breathing. Follow emergency dispatcher instructions regarding rescue breathing or CPR.
Place the Person on Their Side
The recovery position can reduce the risk of choking if vomiting occurs.
Stay With Them
Naloxone’s effect is temporary. Symptoms can return, and another dose may be needed according to product instructions and emergency guidance.
How to Use Naloxone Nasal Spray
This short video from the U.S. Centers for Disease Control and Prevention demonstrates how naloxone nasal spray is administered.
Source: Centers for Disease Control and Prevention. Published April 2024.
Why People Treated With Naltrexone Should Still Have Naloxone
The current FDA prescribing information for extended-release naltrexone specifically recommends discussing access to an opioid-overdose reversal agent with patients and caregivers.
Naloxone is available over the counter in the United States.
Keep It Accessible
Naloxone should be somewhere family or close contacts can reach immediately.
Tell Your Family
They should know where it is and why you have it.
Learn Before the Crisis
Read the instructions and watch a practical demonstration now, not during an emergency.
Check the Product
Know which naloxone formulation you have and check its expiration date periodically.
A naloxone kit that nobody can find or nobody knows how to use is not an effective emergency plan.
Starting Naltrexone Safely After Opioid Use
Naltrexone can abruptly displace opioid effects in somebody who remains physically dependent on opioids.
This can precipitate a severe withdrawal syndrome.
The current U.S. prescribing information for extended-release injectable naltrexone generally recommends a minimum opioid-free interval of 7–10 days for people previously dependent on short-acting opioids.
People transitioning from methadone or buprenorphine can remain vulnerable to precipitated withdrawal for longer, including up to approximately two weeks according to the FDA label.
This is why the correct opioid-free preparation period should be determined clinically rather than copied from another patient’s schedule.
Taking naltrexone while significant opioid dependence remains can produce abrupt withdrawal severe enough to require hospital treatment.
Before Starting, the Clinician May Need to Know:
- which opioids have been used;
- when the last opioid was taken;
- whether fentanyl exposure is possible;
- whether methadone or buprenorphine has been used;
- the current level of physical dependence;
- other medications and medical conditions;
- whether the patient is currently in withdrawal.
What Is Precipitated Opioid Withdrawal?
Spontaneous opioid withdrawal develops as opioid levels gradually fall.
Precipitated withdrawal is different.
An opioid antagonist can cause withdrawal to begin abruptly in somebody who remains physically dependent.
FDA postmarketing reports include cases severe enough to require hospital admission and, in some cases, intensive care.
The correct response is appropriate detoxification and clinical assessment before antagonist therapy begins.
Naltrexone Does Not Treat Acute Alcohol Withdrawal
Naltrexone can have a role in treatment for alcohol use disorder, particularly after appropriate assessment and stabilization.
It does not eliminate acute alcohol withdrawal.
The FDA prescribing information for extended-release naltrexone explicitly states that it does not eliminate or diminish alcohol withdrawal symptoms.
For somebody who drinks heavily and has developed physical alcohol dependence, abruptly stopping alcohol can sometimes cause serious or life-threatening withdrawal.
A history of severe alcohol withdrawal, seizures, delirium, very heavy daily drinking or significant medical illness warrants professional withdrawal-risk assessment.
Naltrexone may become part of the longer-term treatment plan, but withdrawal management and relapse-prevention medication are separate clinical questions.
What Happens if You Need Emergency Pain Treatment While on Naltrexone?
Naltrexone can make ordinary opioid pain medication less effective while antagonist activity is present.
This becomes important after serious injury, emergency surgery, kidney stones, major dental trauma or another condition associated with severe acute pain.
The FDA label for extended-release injectable naltrexone recommends considering regional analgesia or non-opioid analgesics during an emergency.
If opioid therapy is medically necessary despite naltrexone blockade, FDA guidance calls for close monitoring by appropriately trained clinicians in a setting equipped for airway management, assisted ventilation and cardiopulmonary resuscitation.
“I am being treated with naltrexone.”
If you have a long-acting implant, also tell them when it was inserted, which clinic provided it and what product was used if known.
Planned Surgery, Dental Procedures and Naltrexone
Planned procedures give the treatment team time to build a pain-control plan before the procedure occurs.
The surgeon, anesthesiologist, dentist and naltrexone prescriber should know that antagonist treatment is being used.
Perioperative recommendations vary according to naltrexone formulation, timing, indication and the procedure.
Oral tablets, monthly injections and implants cannot automatically be managed using the same timetable.
Before a Planned Procedure:
- tell the medical team you are taking naltrexone;
- identify the exact formulation if possible;
- tell them the date of the last dose or implant insertion;
- discuss expected postoperative pain;
- ask about regional and non-opioid analgesia;
- coordinate any interruption and restart with the addiction clinician;
- plan protection against return to opioid use if naltrexone is interrupted.
Perioperative naltrexone management remains an area where evidence is limited and individualized clinical planning is important.
Tell Clinicians and Pharmacists About Naltrexone Before Taking New Medicines
Naltrexone can interfere with the effects of opioid-containing medications.
These may include more than strong prescription painkillers.
Pain Medicines
Some prescription pain medications contain opioids.
Cough Medicines
Certain prescription cough preparations can contain opioids.
Other Medicines
Some medications used for diarrhea or other conditions may act through opioid receptors.
Before using a new prescription or over-the-counter medicine, tell the clinician or pharmacist that you are receiving naltrexone.
Ask a pharmacist if you are unsure whether a medicine contains an opioid or could interact with naltrexone treatment.
Other Serious Symptoms That Need Medical Attention
Naltrexone treatment has other potential safety issues that patients should understand.
Possible Liver Injury
Seek clinical advice for symptoms such as yellowing of the skin or eyes, dark urine or significant unexplained abdominal symptoms.
Severe Allergic Reaction
Trouble breathing, swelling of the face or tongue, collapse or other signs of anaphylaxis require emergency care.
Depression or Suicidal Thinking
Significant worsening of mood or suicidal thoughts requires prompt assessment. Immediate danger requires emergency help.
Injection / Implant Complication
Increasing redness, severe swelling, drainage, wound breakdown, fever or severe persistent pain around a treatment site should be medically assessed.
In the United States, call or text 988 for suicide or crisis support. If there is immediate danger, call 911.
Naltrexone Implant Safety: What Patients Should Know
A long-acting naltrexone implant is designed to release naltrexone over an extended period, reducing reliance on taking a tablet every day.
That prolonged antagonist exposure can be attractive to people who prefer an abstinence-based antagonist approach and want fewer medication-adherence decisions.
But a long duration makes emergency planning more important, not less.
Know the Product
Different implant products have different doses, release profiles and durations.
Carry Medical Information
Emergency clinicians need to know that opioid antagonism may still be present.
Keep Naloxone Available
Long-acting naltrexone does not remove the need for overdose preparedness.
Plan the End of Treatment
The period when antagonist effects decline deserves explicit relapse and overdose planning.
U.S. Regulatory Status
For U.S. readers, an important distinction is that naltrexone implants are not FDA-approved for clinical use in the United States.
The FDA-approved long-acting naltrexone formulation for opioid use disorder is extended-release intramuscular naltrexone.
Implant regulatory status differs across countries and products.
Safety information from monthly injectable naltrexone helps explain important antagonist principles, but an implant’s exact release profile, duration and perioperative management should be confirmed with the treating clinic and product-specific medical information.
Where a Long-Acting Implant May Fit
For a clinically appropriate patient who has completed the required preparation, long-acting naltrexone may provide sustained antagonist support while the person works on counseling, triggers, relationships, routines and relapse-prevention planning.
The implant should therefore be viewed as one layer of a wider recovery strategy — not as a guarantee that relapse or overdose cannot occur.
Safety Planning Should Begin Before Treatment
A DeBinge consultation can discuss the substance being used, opioid dependence, withdrawal preparation, current medications, previous treatment, medical history, pain-management needs, naloxone access and whether long-acting antagonist treatment may be clinically appropriate.
The consultation should also identify situations where another treatment approach — including buprenorphine or methadone for opioid use disorder — may be more appropriate.
Naltrexone Is One of Several Medication Options for Opioid Use Disorder
In the United States, the three principal FDA-approved medications used for opioid use disorder are methadone, buprenorphine and naltrexone.
They work differently.
Methadone
Activates opioid receptors in a controlled treatment setting and has strong evidence for retention and mortality reduction.
Buprenorphine
Partially activates opioid receptors and is an established evidence-based treatment for opioid use disorder.
Naltrexone
Blocks opioid receptors and requires successful opioid withdrawal before treatment can begin.
The safest treatment is not necessarily the one with the longest duration or the strongest marketing claim.
It is the treatment whose benefits, risks, initiation requirements, patient preference and evidence fit the individual patient.
The Naltrexone Family Emergency Plan
Safety improves when emergency information is shared before a crisis.
Everyone close to the patient should know where it is.
Unresponsiveness and abnormal breathing require immediate action.
Family members should know the formulation and treating clinic.
Keep the clinic contact details and treatment date accessible.
Reduced tolerance can make return to opioids particularly dangerous.
Naloxone does not replace 911 or emergency medical assessment.
Every household with significant opioid-overdose risk should be able to answer three questions immediately: Where is the naloxone? How do we use it? Who calls 911?
How Prepared Are You for Naltrexone-Related Safety Risks?
This self-check is designed to identify which part of your safety plan needs attention and provide a practical roadmap.
It does not diagnose a medical condition and its score is not a validated medical scale.
Your answers are grouped into practical safety areas: overdose emergency, naloxone preparedness, opioid-blockade risk, starting naltrexone safely, pain and surgery, alcohol withdrawal, and medical warning signs.
This Takes About 3–5 Minutes
Answer based on your current situation or the situation of the person you are helping.
Deal With the Emergency Before Anything Else
For suspected opioid overdose: give naloxone if available, call 911, support breathing, place the person on their side and stay until emergency help arrives.
For immediate suicide or self-harm danger, call 911. In the United States, call or text 988 for crisis support.
Need Help Building a Naltrexone Safety Plan?
If you are considering long-acting naltrexone or already have an implant and are unsure about opioid exposure, withdrawal preparation, pain treatment or follow-up, discuss it with an appropriately qualified clinician.
Book a Free DeBinge Consultation →Educational tool only. This self-check is not a validated medical screening test and cannot determine whether naltrexone or an implant is appropriate for you.
Naltrexone Safety FAQ
1. Does naltrexone prevent every opioid overdose?
No. It can block opioid effects while sufficient antagonist activity is present, but fatal overdose can occur if someone attempts to overcome the blockade or when blockade decreases and tolerance is lower.
2. Is naltrexone the same as naloxone?
No. Naltrexone is used for ongoing treatment. Naloxone is used to rapidly reverse a suspected opioid overdose.
3. Should somebody on naltrexone still have naloxone?
Yes. Current FDA guidance for extended-release naltrexone emphasizes access to an opioid-overdose reversal agent.
4. What should I do if somebody overdoses while on naltrexone?
Give naloxone if available, call 911, support breathing, place the person on their side and stay with them until emergency help arrives.
5. Can somebody overcome naltrexone by taking enough opioids?
The blockade can be surmountable, but attempting to overcome it by taking large opioid quantities is extremely dangerous and can cause fatal overdose.
6. Why can overdose risk rise after naltrexone ends?
Opioid tolerance may be lower after abstinence. A previously tolerated dose can therefore become dangerous.
7. How long must somebody be opioid-free before naltrexone?
Timing depends on the opioid and the patient. Current FDA labeling for extended-release injectable naltrexone generally recommends at least 7–10 opioid-free days after short-acting opioids, while methadone and buprenorphine transitions can require longer clinical planning.
8. What happens if naltrexone is taken too early?
It can precipitate abrupt opioid withdrawal, which can sometimes become severe enough to require hospital care.
9. Does naltrexone detox somebody from alcohol?
No. It does not eliminate acute alcohol withdrawal. Withdrawal risk must be assessed separately.
10. What if I need emergency opioid pain relief?
Tell the emergency team that you are using naltrexone. Non-opioid and regional analgesia may be considered. If opioids are medically required despite blockade, close specialist monitoring may be necessary.
11. Should I tell my dentist about naltrexone?
Yes, especially when a procedure may require significant pain medication.
12. Should I carry a medical alert card?
It is a practical safety measure, particularly with long-acting formulations or implants.
13. Can cough medicines interact with naltrexone?
Some prescription products contain opioid ingredients. Ask your clinician or pharmacist when unsure.
14. Are naltrexone implants FDA-approved in the United States?
No. The FDA-approved long-acting naltrexone formulation for opioid use disorder is extended-release intramuscular naltrexone.
15. Does an implant provide exactly the same blockade every day?
Implant release profiles vary by product and over time. Patients should not assume identical blockade throughout the entire expected treatment period.
16. Is a naltrexone implant always safer than methadone or buprenorphine?
No. Each treatment has different benefits, risks and evidence. Treatment choice should be individualized.
17. What serious symptoms should I report?
Serious allergic symptoms, possible liver injury, severe treatment-site reactions, major depression or suicidal thinking require medical assessment.
18. Can a family member administer naloxone?
Yes. Naloxone nasal sprays are designed so non-medical bystanders can administer them during suspected opioid overdose.
19. If naloxone wakes somebody up, do I still call 911?
Yes. Naloxone is temporary and overdose symptoms can return.
20. What is the most important naltrexone safety plan?
Appropriate opioid-free preparation, no attempts to override blockade, naloxone access, family education, emergency medical information, appropriate pain planning and continuing addiction treatment all matter.
Long-Acting Naltrexone Should Come With a Long-Term Safety Plan
A successful treatment plan should address more than simply inserting an implant or administering medication.
Patients and families should understand opioid-free preparation, overdose risk, naloxone access, pain emergencies, surgery planning, end-of-blockade vulnerability, counseling and follow-up.
If you are exploring long-acting naltrexone, DeBinge can discuss the treatment model and whether an antagonist-based approach may be appropriate for your circumstances.
Scientific References and Authoritative Guidance
U.S. FDA — Vivitrol Prescribing Information, Revised December 2025
Current prescribing information covering opioid-free preparation, overdose vulnerability, attempts to overcome blockade, naloxone/nalmefene access, emergency pain management, liver warnings and alcohol withdrawal.
Read FDA Prescribing Information →SAMHSA — Naltrexone
Current U.S. patient information on naltrexone, overdose risk, opioid-free preparation and serious side effects.
Read SAMHSA Guidance →CDC — What to Do if You Think Someone Is Overdosing
Practical U.S. emergency response guidance covering naloxone, calling 911, breathing and recovery positioning.
Read CDC Emergency Guidance →CDC — Lifesaving Naloxone
Patient and family information on how naloxone works and practical overdose reversal.
Read CDC Naloxone Guidance →FDA — Information About Naloxone and Nalmefene
U.S. FDA information on opioid-overdose reversal medications and over-the-counter naloxone.
Read FDA Guidance →SAMHSA — Opioid Overdose Prevention and Reversal
Guidance for recognizing overdose and acting until emergency services arrive.
Read SAMHSA Overdose Guidance →SAMHSA TIP 63 — Medications for Opioid Use Disorder
U.S. treatment guidance covering methadone, buprenorphine, naltrexone and comprehensive opioid-use-disorder treatment.
Read TIP 63 →Cochrane 2025 — Sustained-Release Naltrexone for Opioid Dependence
Updated review of injectable and implantable sustained-release naltrexone compared with agonist treatment, oral naltrexone, placebo and treatment as usual.
Read Cochrane Review →Perioperative Naltrexone Management — 2024 Scoping Review
Review examining perioperative strategies and the limitations of current evidence around naltrexone and surgery.
Read on PubMed →SAMHSA — Implant Regulatory Status
SAMHSA material distinguishes the FDA-approved extended-release injectable formulation from subdermal implants, which are not FDA-approved in the United States.
Read SAMHSA Publication →Safety guidance for FDA-approved extended-release injectable naltrexone cannot automatically define the exact pharmacokinetics, duration or emergency-management timetable of every implant product. Implant-specific advice should come from the treating clinician and the medical information for that specific product.
Prepared for medical review by Dr. Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry
Review status: Pending clinical approval
This article provides general education only. It is not personal medical advice and should not delay emergency care.
Naltrexone can be an important part of treatment for opioid use disorder and alcohol use disorder, but using it safely requires understanding one critical point: naltrexone does not make opioid overdose impossible.
Naltrexone is an opioid-receptor antagonist. While sufficient antagonist activity is present, it can block or substantially reduce the effects of opioid drugs.
That blockade can support recovery, but it also creates safety issues that patients, families, emergency clinicians, dentists and surgeons should understand before an emergency occurs.
One danger is attempting to use increasingly large amounts of opioids because the expected opioid effect cannot be felt.
Another important risk period occurs when naltrexone activity decreases, treatment is missed or treatment ends. Opioid tolerance may now be lower, meaning a dose that was previously tolerated can become substantially more dangerous.
Naltrexone must also be distinguished from naloxone.
Naltrexone is used as part of ongoing treatment. Naloxone is an emergency medication used to reverse opioid overdose.
This guide explains overdose risk, emergency response, naloxone, opioid-free preparation, precipitated withdrawal, surgery and pain management, alcohol withdrawal, long-acting naltrexone implants and how to build a practical safety plan.
Do Not Continue Reading Instead of Seeking Emergency Help
If somebody cannot be awakened, has very slow or stopped breathing, has choking or gurgling breathing, or you suspect opioid overdose:
- Give naloxone if available.
- Call 911 immediately.
- Try to keep the person awake and breathing.
- Follow emergency-dispatch instructions regarding rescue breathing or CPR.
- Place the person on their side when appropriate to reduce choking risk.
- Stay with them until emergency help arrives.
If you are outside the United States, contact your local emergency medical service.
When overdose risk can increase, how naloxone differs from naltrexone, how to recognize an opioid overdose, how to prepare for surgery or severe pain, why opioid-free preparation matters and how to build your own practical naltrexone safety roadmap.
Prepared for medical review by Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry
Review status: Pending clinical approval
View Dr Fergus Law’s Clinical & Scientific Profile →What Naltrexone Does — and Does Not Do
Naltrexone is an opioid-receptor antagonist.
It binds to opioid receptors without producing the opioid effects caused by opioid agonists.
When sufficient antagonist activity is present, the rewarding, euphoric and sedating effects of opioids may be substantially reduced.
In the United States, extended-release intramuscular naltrexone is an FDA-approved medication used for opioid use disorder following opioid detoxification and for alcohol dependence in appropriate patients.
Naltrexone should be part of a wider recovery strategy rather than treated as a replacement for behavioral treatment, counseling, relapse prevention and medical follow-up.
Blocks Opioid Receptors
Opioid effects may be substantially reduced while sufficient antagonist activity remains.
Can Support Recovery
Antagonist treatment can provide additional structure while a person works on triggers, behavior and recovery.
Does Not Replace Naloxone
Naltrexone is not the medication used to reverse an opioid overdose.
Opioid blockade should never be interpreted as permission to experiment with opioids or test how much opioid could overcome the blockade.
Naltrexone vs Naloxone
If somebody being treated with naltrexone experiences an opioid overdose, naloxone is the emergency medication. Do not attempt to treat an overdose by giving additional naltrexone.
Can You Overdose on Opioids While on Naltrexone?
Yes.
Naltrexone can provide strong opioid-receptor blockade, but that blockade should never be described as absolute protection against overdose.
FDA prescribing information specifically warns that attempts to overcome opioid blockade may lead to fatal overdose.
Another important risk occurs when antagonist activity decreases, after treatment has been missed or after treatment is discontinued.
During a period without regular opioid exposure, tolerance may fall. This means a dose previously tolerated before treatment can become much more dangerous later.
Attempting to Override Naltrexone
Taking increasingly large opioid amounts because the expected effect is blocked can create life-threatening exposure.
Blockade Has Weakened or Ended
Reduced tolerance can make a previously familiar opioid dose unexpectedly dangerous.
It is better understood as one component of treatment and relapse prevention. Overdose preparedness still matters.
Why Trying to Overcome Naltrexone Can Be Dangerous
Somebody may expect that if an opioid does not produce the usual effect, taking more will eventually “break through.”
This is an especially dangerous response to antagonist treatment.
Why the End of Naltrexone Treatment Can Become a High-Risk Period
Opioid tolerance can decline during abstinence.
Somebody receiving naltrexone may therefore spend a prolonged period without the opioid doses they previously tolerated.
If antagonist activity later decreases and the person returns to opioid use, their previous dose may no longer be safe.
End of Dose Interval
Antagonist activity does not remain identical indefinitely.
Missed Treatment
Missing scheduled treatment can create uncertainty about remaining blockade.
Treatment Discontinuation
Opioid tolerance may now be significantly lower than before treatment.
Long-Acting Implant
An estimated implant duration should not be interpreted as identical blockade on every day of that period.
Implant products can differ in dose, release profile and duration. Follow-up should include an explicit plan for the period when antagonist activity is expected to decline.
Signs of an Opioid Overdose
Opioid overdose becomes life-threatening primarily because opioids can suppress the brain’s drive to breathe.
If you are unsure whether somebody is simply intoxicated or experiencing overdose, treat the situation as a suspected overdose and seek emergency help.
The person is unconscious or does not respond normally.
Breathing may be extremely slow, irregular or may stop.
Abnormal breathing sounds in somebody who cannot be awakened can indicate overdose.
Lips, nails or skin can change color as oxygen levels fall.
Profound unresponsiveness is a medical emergency.
Small constricted pupils can occur, although this sign alone does not establish an overdose.
Emergency Protocol for Suspected Opioid Overdose
Give Naloxone
Administer naloxone immediately if it is available.
Call 911
Emergency medical assessment is still necessary even if the person responds to naloxone.
Support Breathing
Try to keep the person awake and breathing and follow emergency dispatcher instructions about rescue breathing or CPR.
Place Them on Their Side
The recovery position can reduce choking risk.
Stay With Them
More than one dose of naloxone may sometimes be required. Stay until emergency help arrives.
How to Use Naloxone Nasal Spray
The U.S. Centers for Disease Control and Prevention provides this practical demonstration of how naloxone nasal spray is administered during a suspected opioid overdose.
Source: U.S. Centers for Disease Control and Prevention.
Why People Using Naltrexone Should Still Have Naloxone Available
Current FDA prescribing information for extended-release naltrexone emphasizes access to an opioid-overdose reversal agent for people at risk.
Naloxone is available over the counter in the United States.
Keep It Accessible
Naloxone should be somewhere family or close contacts can reach quickly.
Tell Other People
Because you cannot give naloxone to yourself during an unconscious overdose, other people should know it is available.
Learn Before the Emergency
Watch the demonstration and read the instructions before a crisis occurs.
Check Your Supply
Know which naloxone formulation you have and check it periodically.
A naloxone product that nobody can find or knows how to administer is not an effective emergency plan.
Starting Naltrexone Safely After Opioid Use
Naltrexone can abruptly antagonize opioid receptors in somebody who remains physically dependent on opioids.
This can precipitate severe withdrawal.
The current U.S. prescribing information for extended-release injectable naltrexone recommends a minimum opioid-free period of 7–10 days before initiation.
SAMHSA TIP 63 provides more detailed guidance and notes that people should typically wait 7–10 days after short-acting opioids and 10–14 days after long-acting opioids before naltrexone initiation.
The correct preparation period should therefore be determined from the patient’s actual opioid exposure, physical dependence and clinical circumstances rather than copied from another person’s treatment schedule.
Taking naltrexone before adequate opioid clearance can trigger abrupt withdrawal severe enough to require medical or hospital care.
Before Starting, the Treatment Team May Need to Know:
- which opioid or opioids have been used;
- when the last opioid was taken;
- whether fentanyl exposure is possible;
- whether methadone or buprenorphine has been used;
- the person’s current level of physical dependence;
- current medications;
- relevant medical conditions;
- whether opioid withdrawal is currently present.
What Is Precipitated Opioid Withdrawal?
Ordinary opioid withdrawal develops as opioid activity falls after the body has become physically dependent.
Precipitated withdrawal can occur when an opioid antagonist is introduced while significant opioid dependence remains.
Symptoms can begin abruptly and can be severe.
Naltrexone should be initiated only after adequate opioid withdrawal and appropriate clinical assessment.
Naltrexone Does Not Treat Acute Alcohol Withdrawal
Naltrexone can be used as part of longer-term treatment for alcohol use disorder in appropriate patients.
It should not be confused with treatment of acute alcohol withdrawal.
Somebody with substantial physical alcohol dependence may experience serious withdrawal if alcohol is stopped abruptly.
Severe withdrawal can include seizures, delirium and medical instability.
Previous withdrawal seizures, delirium, severe withdrawal, substantial daily drinking or significant medical illness should prompt professional assessment before an unsupervised detox attempt.
What if You Need Emergency Pain Treatment While on Naltrexone?
Naltrexone can make opioid pain medication less effective while sufficient antagonist activity remains.
This becomes important during serious trauma, emergency surgery, major dental injury, kidney stones or other painful medical emergencies.
FDA guidance for extended-release injectable naltrexone notes that regional analgesia and non-opioid analgesics can be considered in emergencies.
If opioid medication becomes medically necessary despite blockade, specialist monitoring may be required in an appropriately equipped setting.
“I am receiving naltrexone treatment.”
If you have an implant, also tell them approximately when it was inserted, which clinic provided it and which product was used if known.
Planned Surgery, Dental Procedures and Naltrexone
Planned procedures provide time for the addiction-treatment team and the surgical or dental team to develop a pain-management strategy.
The surgeon, anesthesiologist, dentist and naltrexone clinician should know which formulation is being used.
Oral naltrexone, monthly injections and long-acting implants should not automatically be treated as though they have identical pharmacokinetics.
Before a Planned Procedure:
- tell the medical team that you are receiving naltrexone;
- identify the formulation if possible;
- provide the date of the last injection or implant insertion;
- discuss the amount of pain expected after the procedure;
- ask about regional and non-opioid pain-management options;
- coordinate treatment changes with the addiction clinician;
- create a relapse-prevention plan if antagonist treatment is interrupted.
Tell Clinicians and Pharmacists About Naltrexone Before Taking New Medicines
Naltrexone can antagonize opioid-containing medicines.
Opioid ingredients are not limited to strong prescription pain medication.
Pain Medicines
Some prescription analgesics contain opioids.
Cough Medicines
Certain prescription cough preparations can contain opioid ingredients.
Other Medicines
Some medications used for diarrhea and other conditions can also act through opioid receptors.
Before taking a new prescription or over-the-counter medicine, tell the doctor or pharmacist that you are receiving naltrexone.
Other Serious Symptoms That Need Medical Attention
Possible Liver Injury
Yellowing of the skin or eyes, dark urine or significant unexplained abdominal symptoms should be medically assessed.
Severe Allergic Reaction
Trouble breathing, facial or tongue swelling, collapse or other signs of anaphylaxis require emergency medical attention.
Depression or Suicidal Thinking
Significant worsening of mood or suicidal thoughts requires prompt assessment. Immediate danger requires emergency help.
Injection or Implant-Site Problems
Increasing redness, drainage, swelling, severe pain, wound breakdown or fever should be medically assessed.
In the United States, call or text 988 for suicide and crisis support. If there is immediate danger, call 911.
Naltrexone Implant Safety: What Patients Should Understand
A naltrexone implant is designed to release naltrexone over an extended period, reducing reliance on remembering a tablet every day.
For an appropriately selected patient, sustained antagonist exposure may provide a longer period in which recovery work, counseling and behavioral change can take place.
But long duration makes emergency planning more important, not less.
Know the Product
Implant products can differ in dose, formulation and release profile.
Carry Medical Information
Emergency clinicians should be able to discover that opioid antagonism may still be present.
Keep Naloxone Available
A long-acting antagonist does not eliminate the need for overdose preparedness.
Plan the End of Treatment
The period when antagonist activity declines deserves specific relapse and overdose planning.
U.S. Regulatory Status
For U.S. readers, it is important to distinguish a naltrexone implant from FDA-approved extended-release injectable naltrexone.
FDA-approved medication options for opioid use disorder include extended-release intramuscular naltrexone. A naltrexone implant is not an FDA-approved U.S. formulation.
Implant regulatory status differs according to country and product.
Safety principles from FDA-approved injectable naltrexone help explain antagonist treatment, but an implant’s exact release profile, duration and emergency-management timetable should be confirmed using product-specific information and the treating clinician.
Where a Long-Acting Implant May Fit
For a clinically appropriate patient who has completed the required preparation, long-acting naltrexone may provide sustained antagonist support while counseling and relapse-prevention work continue.
It should be treated as one layer of a comprehensive treatment strategy, not as a guarantee that return to opioid use or overdose cannot occur.
Safety Planning Should Begin Before Treatment
A DeBinge consultation can discuss opioid or alcohol use, physical dependence, withdrawal preparation, previous treatment, current medications, pain-management needs, naloxone access and whether antagonist treatment may be clinically appropriate.
Naltrexone Is One of Several Medication Options for Opioid Use Disorder
In the United States, medication treatment for opioid use disorder includes methadone, buprenorphine and naltrexone.
They work differently and have different initiation requirements, advantages, limitations and evidence.
Methadone
An established treatment with strong evidence for treatment retention and reduced mortality in opioid use disorder.
Buprenorphine
An established evidence-based treatment that partially activates opioid receptors.
Naltrexone
Blocks opioid receptors and requires successful withdrawal from opioids before treatment initiation.
The safest treatment is not automatically the longest-lasting treatment.
The appropriate choice depends on the person’s clinical situation, evidence, treatment goals, ability to initiate therapy safely and informed preference.
Build a Naltrexone Family Emergency Plan
Everyone close to the patient should know where it is.
Unresponsiveness and abnormal breathing require immediate action.
Family members should know whether treatment is oral, injectable or implant-based.
Keep treatment dates, product information and clinic contact details accessible.
Returning to a previous opioid dose after abstinence can be dangerous.
Naloxone is an emergency tool but does not replace medical assessment.
Where is the naloxone? Who knows how to use it? Who calls 911?
How Prepared Are You for Naltrexone-Related Safety Risks?
This self-check identifies which part of your safety plan may need attention and turns your answers into a practical next-step roadmap.
It is not a diagnostic test, and the internal scoring is not presented as a medical diagnosis.
This Takes About 3–5 Minutes
Answer based on your current situation or on the situation of the person you are helping.
Deal With the Emergency Before Anything Else
If opioid overdose is suspected, give naloxone if available and call 911 immediately.
Try to keep the person breathing, follow dispatcher instructions, place them on their side when appropriate and stay until emergency medical help arrives.
For immediate suicide or self-harm danger, call 911. In the United States, call or text 988 for crisis support.
Need Help Understanding Your Naltrexone Safety Plan?
If you are considering long-acting naltrexone or already have an implant and have questions about preparation, opioid exposure, pain treatment or follow-up, discuss your situation with an appropriately qualified clinician.
Book a Free DeBinge Consultation →Educational planning tool only. This is not a validated diagnostic instrument and cannot determine whether naltrexone, an implant or another treatment is appropriate for you.
Naltrexone Safety FAQ
1. Does naltrexone prevent every opioid overdose?
No. Fatal overdose can occur when somebody attempts to overcome blockade or when blockade decreases and opioid tolerance is lower.
2. Is naltrexone the same as naloxone?
No. Naltrexone is used as part of ongoing treatment. Naloxone is used to reverse a suspected opioid overdose.
3. Should somebody using naltrexone still keep naloxone?
Yes. Overdose preparedness remains relevant during naltrexone treatment.
4. What should I do if somebody overdoses while on naltrexone?
Give naloxone if available, call 911, support breathing, place the person on their side when appropriate and stay until emergency help arrives.
5. Can naltrexone blockade be overcome with opioids?
The blockade can potentially be surmounted, but attempting to do so with high opioid doses can cause fatal overdose.
6. Why can overdose risk increase when treatment ends?
Opioid tolerance may be lower after abstinence, making a previously tolerated dose dangerous.
7. How long must somebody be opioid-free before naltrexone?
The FDA label for extended-release injectable naltrexone recommends a minimum opioid-free interval of 7–10 days. SAMHSA TIP 63 describes 7–10 days after short-acting opioids and typically 10–14 days after long-acting opioids.
8. What happens if naltrexone is started too early?
It can precipitate abrupt opioid withdrawal, which can become severe.
9. Does naltrexone treat acute alcohol withdrawal?
No. Alcohol-withdrawal risk needs separate clinical assessment.
10. What if I need emergency pain medication?
Tell the medical team that you are receiving naltrexone. Regional and non-opioid approaches may be considered, and specialist monitoring may be required if opioid analgesia becomes necessary.
11. Should my dentist know about naltrexone?
Yes, particularly before procedures expected to require significant pain management.
12. Should I carry a medical alert card?
It can be a useful practical safety measure, especially for people using long-acting formulations.
13. Can prescription cough medicines contain opioids?
Some can. Ask a pharmacist or clinician if you are unsure.
14. Are naltrexone implants FDA-approved in the United States?
No. The FDA-approved long-acting antagonist formulation for opioid use disorder is extended-release intramuscular naltrexone, not a naltrexone implant.
15. Does an implant provide exactly the same blockade every day?
Implant formulations have release profiles that change over time, so identical antagonist activity should not be assumed throughout the entire estimated duration.
16. Is an implant automatically safer than methadone or buprenorphine?
No. Each treatment has different benefits, risks and evidence. Treatment should be individualized.
17. What symptoms should be medically assessed?
Severe allergic symptoms, possible liver injury, significant treatment-site reactions and major worsening of depression or suicidal thinking should be assessed.
18. Can a family member administer naloxone?
Yes. Naloxone nasal spray can be administered by a bystander during suspected opioid overdose.
19. If naloxone wakes somebody up, should I still call 911?
Yes. Overdose effects can return and additional treatment can still be necessary.
20. What should a strong naltrexone safety plan include?
Appropriate opioid-free preparation, naloxone access, no attempts to overcome blockade, emergency medical information, pain planning, end-of-treatment planning, counseling and continuing recovery support.
Long-Acting Naltrexone Should Come With a Long-Term Safety Plan
A complete treatment plan should address more than administering medication or inserting an implant.
Patients and families should understand opioid-free preparation, overdose risk, naloxone access, surgery and pain planning, end-of-blockade vulnerability, counseling and continuing follow-up.
If you are exploring long-acting naltrexone, DeBinge can explain the treatment model and discuss whether antagonist-based treatment may be appropriate for your situation.
Scientific References and Safety Guidance
U.S. FDA — Vivitrol Prescribing Information, Revised December 2025
Current prescribing information covering opioid-free preparation, overdose vulnerability, attempts to overcome blockade, opioid-overdose reversal medication, emergency pain management, liver warnings and other safety issues.
Read FDA Prescribing Information →SAMHSA TIP 63 — Chapter 3C: Naltrexone
SAMHSA guidance covering naltrexone pharmacology, opioid-free preparation, precipitated withdrawal, overdose vulnerability, patient assessment and treatment considerations. This copy is hosted by the U.S. National Library of Medicine / NIH rather than the SAMHSA website.
Read SAMHSA Naltrexone Guidance on NCBI →CDC — What to Do if You Think Someone Is Overdosing
Current U.S. public-health instructions covering naloxone, calling 911, breathing support, recovery positioning and remaining with the person until emergency help arrives.
Read CDC Overdose Response Guidance →CDC — Lifesaving Naloxone
Current CDC information explaining how naloxone reverses opioid overdose, who should carry it and how it is used.
Read CDC Naloxone Guidance →FDA — Information About Medications for Opioid Use Disorder
FDA information about buprenorphine, methadone and extended-release naltrexone used in treatment for opioid use disorder.
Read FDA MOUD Guidance →SAMHSA TIP 63 — Medications for Opioid Use Disorder
The complete SAMHSA Treatment Improvement Protocol covering methadone, buprenorphine, naltrexone and wider strategies used to support opioid use disorder recovery. This version is hosted by the U.S. National Library of Medicine / NIH.
Read Full SAMHSA TIP 63 on NCBI →Safety information for FDA-approved extended-release injectable naltrexone helps explain important opioid-antagonist principles, but it does not automatically define the precise pharmacokinetics, duration or emergency-management timetable of every implant product. Implant-specific advice should come from the treating clinician and product-specific medical information.
Prepared for medical review by Dr Fergus Law, BSc, MBChB, FRCPsych
Consultant Psychiatrist specialising in substance misuse and addiction psychiatry
Review status: Pending clinical approval
This article provides general education only. It does not replace individualized medical assessment and should never delay emergency care.